Articles with public access mandates - Suet Feung ChinLearn more
Not available anywhere: 5
Review
Therapeutic rationale to target highly expressed CDK7 conferring poor outcomes in triple-negative breast cancer
B Li, T Ni Chonghaile, Y Fan, SF Madden, R Klinger, AE O'Connor, ...
Cancer research 77 (14), 3834-3845, 2017
Mandates: Science Foundation Ireland, Cancer Research UK, UK Medical Research Council …
Review
Genomic gain of 5p15 leads to over-expression of Misu (NSUN2) in breast cancer
M Frye, I Dragoni, SF Chin, I Spiteri, A Kurowski, E Provenzano, A Green, ...
Cancer letters 289 (1), 71-80, 2010
Mandates: Cancer Research UK
Review
Big data in cancer genomics
AT Maia, SJ Sammut, A Jacinta-Fernandes, SF Chin
Current Opinion in Systems Biology 4, 78-84, 2017
Mandates: Fundação para a Ciência e a Tecnologia, Portugal, Cancer Research UK …
Review
BET inhibition as a rational therapeutic strategy for invasive lobular breast cancer
L Walsh, KE Haley, B Moran, B Mooney, F Tarrant, SF Madden, ...
Clinical Cancer Research 25 (23), 7139-7150, 2019
Mandates: Science Foundation Ireland, Breast Cancer Now, UK, Cancer Research UK …
Review
Cameron C. Young, Katherine Eason, Raquel Manzano Garcia, Richard Moulange 3
S Mukherjee, SF Chin, C Caldas, OM Rueda
Scientific Reports 14, 11861, 2024
Mandates: Cancer Research UK, UK Medical Research Council, National Institute for …
Available somewhere: 88
Review
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
C Curtis, SP Shah, SF Chin, G Turashvili, OM Rueda, MJ Dunning, ...
Nature 486 (7403), 346-352, 2012
Mandates: US National Institutes of Health, Cancer Research UK
Review
Analysis of circulating tumor DNA to monitor metastatic breast cancer
SJ Dawson, DWY Tsui, M Murtaza, H Biggs, OM Rueda, SF Chin, ...
New England Journal of Medicine 368 (13), 1199-1209, 2013
Mandates: National Health and Medical Research Council, Australia, Cancer Research UK
Review
The clonal and mutational evolution spectrum of primary triple-negative breast cancers
SP Shah, A Roth, R Goya, A Oloumi, G Ha, Y Zhao, G Turashvili, J Ding, ...
Nature 486 (7403), 395-399, 2012
Mandates: US National Institutes of Health, Cancer Research UK
Review
Differential oestrogen receptor binding is associated with clinical outcome in breast cancer
CS Ross-Innes, R Stark, AE Teschendorff, KA Holmes, HR Ali, ...
Nature 481 (7381), 389-393, 2012
Mandates: Cancer Research UK
Review
The landscape of cancer genes and mutational processes in breast cancer
PJ Stephens, PS Tarpey, H Davies, P Van Loo, C Greenman, DC Wedge, ...
Nature 486 (7403), 400-404, 2012
Mandates: US National Institutes of Health, Research Foundation (Flanders), National …
Review
Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA
M Murtaza, SJ Dawson, DWY Tsui, D Gale, T Forshew, AM Piskorz, ...
Nature 497 (7447), 108-112, 2013
Mandates: National Health and Medical Research Council, Australia, Cancer Research UK
Review
Pan-cancer analysis of whole genomes
Nature 578 (7793), 82-93, 2020
Mandates: US National Institutes of Health, Cancer Research UK, UK Medical Research …
Review
The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes
B Pereira, SF Chin, OM Rueda, HKM Vollan, E Provenzano, HA Bardwell, ...
Nature communications 7 (1), 1-16, 2016
Mandates: Cancer Research UK, National Institute for Health Research, UK
Review
MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype
C Blenkiron, LD Goldstein, NP Thorne, I Spiteri, SF Chin, MJ Dunning, ...
Genome biology 8, 1-16, 2007
Mandates: Cancer Research UK
Review
A reference map of the human binary protein interactome
K Luck, DK Kim, L Lambourne, K Spirohn, BE Begg, W Bian, R Brignall, ...
Nature 580 (7803), 402-408, 2020
Mandates: US National Institutes of Health, American Heart Association, National Fund …
Review
Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer
M Murtaza, SJ Dawson, K Pogrebniak, OM Rueda, E Provenzano, J Grant, ...
Nature communications 6 (1), 8760, 2015
Mandates: Cancer Research UK, UK Medical Research Council, National Institute for …
Review
The shaping and functional consequences of the microRNA landscape in breast cancer
H Dvinge, A Git, S Gräf, M Salmon-Divon, C Curtis, A Sottoriva, Y Zhao, ...
Nature 497 (7449), 378-382, 2013
Mandates: Cancer Research UK
Review
Quantitative image analysis of cellular heterogeneity in breast tumors complements genomic profiling
Y Yuan, H Failmezger, OM Rueda, HR Ali, S Gräf, SF Chin, RF Schwarz, ...
Science translational medicine 4 (157), 157ra143-157ra143, 2012
Mandates: Cancer Research UK
Review
Promoter of lncRNA gene PVT1 is a tumor-suppressor DNA boundary element
SW Cho, J Xu, R Sun, MR Mumbach, AC Carter, YG Chen, KE Yost, J Kim, ...
Cell 173 (6), 1398-1412. e22, 2018
Mandates: US National Institutes of Health, Howard Hughes Medical Institute, Cancer …
Review
Endogenous purification reveals GREB1 as a key estrogen receptor regulatory factor
H Mohammed, C D’Santos, AA Serandour, HR Ali, GD Brown, A Atkins, ...
Cell reports 3 (2), 342-349, 2013
Mandates: Cancer Research UK
Publication and funding information is determined automatically by a computer program